Related references
Note: Only part of the references are listed.Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers
Riccardo Sarzani et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
Flavio A. Cadegiani
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults A Living Systematic Review
Katherine Mackey et al.
ANNALS OF INTERNAL MEDICINE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
Peng Zhang et al.
CIRCULATION RESEARCH (2020)
The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients
Marco Vicenzi et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Management of COVID-19 Respiratory Distress
John J. Marini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review
James M. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical efficacy of potassium canreonate-canrenone in sinus rhythm restoration among patients with atrial fibrillation - a protocol of a pilot, randomized, double -blind, placebo-controlled study (CANREN-AF trial)
Rafal Dabrowski et al.
TRIALS (2020)
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity
Andy Goren et al.
JOURNAL OF COSMETIC DERMATOLOGY (2020)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated
Carlos Gustavo Wambier et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Sex Differences in Case Fatality Rate of COVID-19: Insights From a Multinational Registry
Mohamad Alkhouli et al.
MAYO CLINIC PROCEEDINGS (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
Giuseppe Mancia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis
Stefano Figliozzi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study
Orianne Villard et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality
Francesco Cannata et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Flavio A. Cadegiani et al.
FRONTIERS IN MEDICINE (2020)
Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)
Flavio A. Cadegiani et al.
MEDICAL HYPOTHESES (2020)
Endothelial Dysfunction in Primary Aldosteronism
Zheng-Wei Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases
Wan Shun Daniel Tan et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies
Seema Patel et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs
Decio Armanini et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status
Terry K. W. Ma et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Spironolactone for hypertension
Josh Batterink et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Detection of soluble angiotensin-converting enzyme 2 in heart failure
Slava Epelman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Endothelial dysfunction - A marker of atherosclerotic risk
PO Bonetti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Share Paper
